Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acquired immunodeficiency syndrome
acute disseminated encephalomyelitis
advances in neurology
adverse drug reaction
alemtuzumab
algorithm
amyloid angiopathy, cerebral
angiitis, granulomatous of CNS
angiitis, isolated of CNS
anti DNA agent
anti JC virus antibodies
antibiotics
antiviral agents
asymptomatic
ataxia
atypical
B 12 deficiency
bacterial infection
Behcet's syndrome
biologic markers
brain biopsy
brain biopsy, false negative
brain biopsy, negative
brainstem, lesion of
brentuximab
brucellosis, nervous system involvement with
Brudzinski's sign
carbon monoxide poisoning
carcinoma
CAT scan, abnormal
CAT scan, emission, abnormal
CD4 counts
central nervous system, infection of
central pontine myelinolysis
cerebellar atrophy, secondary
cerebellar degeneration
cerebellar lesion
cerebellum, disease of
cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy
cerebral venous thrombosis
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, gammaglobulin of
cerebrovascular accident, secondary prevention
chemotherapy, CNS treatment and complications with
cladribine
Clinical Pathologic Conference(C.P.C.)
coinfection
Collier's sign
complications
controversies in neurology
cortical blindness
cranial neuropathy
cytosine arabinoside
daclizumab
delay in diagnosis
demyelinating disease
dermatomyositis
disability, neurological
drug abuse
drug holiday
drug induced neurologic disorders
drug withdrawal
dysarthria
efalizumab
efficacy
electroencephalogram, abnormalities of
electron microscopy
encephalitis
encephalitis, brainstem
encephalitis, human immunodeficiency virus type 1
encephalitis, paraneoplastic
encephalitis, viral
epidemiology of neurology
Epstein-Barr virus
etanercept
evidence-based research
false negative
fever
fingolimod
gadolinium
gammaglobulin therapy, intravenous
gaze palsy, vertical
gliomatosis cerebri
Guillain Barre syndrome
hearing loss
hemiparesis
hemiplegia, progressive
hepatosplenomegaly
highly active antiretroviral therapy
Hodgkin's disease
human immunodeficiency virus type 1
hydrocephalus
hypercalcemia
hypertensive encephalopathy
iatrogenic neurologic disorders
immune checkpoint inhibitors
immune reconstitution inflammatory syndrome
immune-related adverse events
immunocompetent
immunofluorescent exam of CSF cells
immunomodulation
immunosuppression
immunosuppressive agents
immunotherapy
in situ hybridization
inclusion bodies
infection
infliximab
interferon
interferon beta 1-a
iododeoxyuridine
JC virus
JC virus cerebellar granule cell neuronopathy
JC virus encephalopathy
Kernig's sign
leukemia
leukemia, neurologic findings assoc.with
leukoencephalopathy
leukoencephalopathy, differential diagnosis
leukoencephalopathy, toxic
levamisole
level of consciousness, decreased
life expectancy
limbic encephalitis
listeriosis, CNS
lymph node biopsy
lymphadenopathy
lymphoma
lymphoma involving CNS
lymphoma, primary of CNS
meningismus
meningitis
midbrain
midbrain, lesion of
middle cerebellar peduncle
middle cerebellar peduncle, lesion
migraine
mitochondrial disease
monoclonal antibodies
mortality
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, diffusion weighted
MRI, magnetization transfer sequence
MRI, negative
MRI, ring sign
MRI, ring sign, open
MRI, serial
MRS
multiple sclerosis
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, relapsing
multiple sclerosis, treatment of
myoclonus
natalizumab
negative
neoplasm, primary of CNS
neurologic complications of, systemic disease
neurologic disease, diagnoses of
neurologic disease, multiple
neurologic signs
neurologic symptoms
neuromyelitis optica (Devic's disease)
neuropathology
neuropathy
neuropathy, iatrogenic
neuropathy, immune
neuropathy, medication induced
neuropathy, motor, multifocal
neuropathy, peripheral, treatment
nivolumab
ocrelizumab
Ommaya reservoir
opportunistic infection
opportunistic infection, CNS
papovavirus
pembrolizumab
phenylketonuria
plasmapheresis
plasmapheresis, complications of
pleocytosis of cerebrospinal fluid
polymerase chain reaction
polymerase chain reaction, false negative
polymyositis
polyneuropathy, chronic inflammatory demyelinating
posterior leukoencephalopathy syndrome
practice guidelines
preclinical
prognosis
progressive multifocal leucoencephalopathy
progressive neurologic disorder
psoriasis
quality of life
radiation therapy, CNS treatment and complications with
remote effect of cancer on the nervous system
review article
rheumatoid arthritis
rheumatoid arthritis, neurologic complications of
risk factors
risk stratification
risk-benefit assessment
rituximab
safety
sarcoidosis
sarcoidosis, CNS
screening
serologic testing
seropositive
slow virus infection of CNS
steroid therapy, CNS treatment and complications with
symmetric brain lesions
systemic lupus erythematosus
treatment of neurologic disorder
tuberculosis
tumor necrosis factor inhibitor
upgaze
vaccination, neurologic complications with
vaccine
vasculitides
vasculopathy
vincristine neurotoxicity
viral infection
viral infection, CNS
weakness, progressive
Whipple's disease
white matter disease
workup
Showing articles 100 to 150 of 3117 << Previous Next >>

Progressive Multifocal Leukoencephalopathy in Transplant Recipients
Ann Neurol 70:305-322, Mateen, F.J.,et al, 2011

Progressive Multifocal Leukoencephalopathy: Prognosis and treatment
UpToDate, June, Koralnik, I.J.,et al, 2011

Toxoplasmic Encephalitis IRIS in HIV-Infected Patients
JNNP 82:691-693, Martin-Blondel, G.,et al, 2011

Infectious and Non-Infectious Neurologic Complications in Heart Transplant Recipients
Medicine 89:166-175, Mu�oz,P., et al, 2010

Clinicopath Conf., Progressive Multifocal Leukoencephalopathy
NEJM 362:1431-1437, Case 11-2010, 2010

Progressive Multifocal Leukoencephalopathy in Individuals with Minimal or Occult Immunosuppression
JNNP 81:247-254, Gheuens,S., et al, 2010

Incidence of Progressive Multifocal Leukoencephalopathy in Patients without HIV
Neurol 75:326-1332, Amend,K.I.,et al, 2010

Challenge of the Unknown: A Systematic Review of Acute Encephalitis in Non-Outbreak Situations
Neurol 75:924-932, Granerod,J. et al, 2010

Imaging Manifestations of Progressive Multifocal Leukoencephalopathy
Clinical Radiol 65:431-439, Shah,R.,et al, 2010

Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab
NEJM 361:1067-1074, Chen,Y.,et al, 2009

Determinants of Survival in Progressive Multifocal Leukoencephalopathy
Neurol 73:1551-1558, Marzocchetti,A.,et al, 2009

Reemergence of PML in Natalizumab-Treated Patients--New Cases, Same Concerns
NEJM 361:1041-1043, Major,E., 2009

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 66:403-406, 261, 262, Schweikert,A.,et al, 2009

Natalizumab and Central Nervous System Lymphoma: No Clear Association
Ann Neurol 66:261-262, Bozic,C.,et al, 2009

Anti-N-Methyl-D-Aspartate Receptor (NHMDAR) Encephalitis in Children and Adolescents
Ann Neurol 66:11-18,1, Florance,N.R.,et al, 2009

Neurologic Immune Reconstitution Inflammatory Syndrome in HIV/AIDS: Outcome and Epidemiology
Neurol 72:835-841, McCombe,J.A.,et al, 2009

PML-IRIS in Patients with HIV Infection: Clinical Manifestations and Treatment with Steroids
Neurol 72:1458-1464,1454, Tan,K.,et al, 2009

Herpes Simplex Encephalitis during Treatment with Tumor Necrosis Factor- Inhibitors
CID 49:924-927, Bradford, R.D.,et al, 2009

Rapidly Progressive Dementia
Ann Neurol 64:97-108, Geschwind,M.D.,et al., 2008

JC Viral Infection-Related Cerebellar Degeneration as the First Manifestation of AIDS
Eur Neurol 59:205-207, Shin,H.-W.,et al, 2008

Post-Transplant Acute Limbic Encephalitis: Clinical Features and Relationship to HHV6
Neurol 69:156-165, Seeley,W.W.,et al, 2007

Inflammatory Progressive Multifocal Leukoencephalopathy in Human Immunodeficiency Virus-Negative Patients
Ann Neurol 62:34-39, Huang,D.R.,et al, 2007

Central Nervous System Infections in Heart Transplant Recipients
Arch Neurol 64:1715-1720, van de Beek,D.,et al, 2007

Reactivation of JC Virus and Development of PML in Patients With Multiple Sclerosis
Neurol 68:985-990, Khalili,K.,et al, 2007

Misdiagnosis of stroke
Expert Rev Neurother 7:989-1001, Nor, A.M.,et al, 2007

Characteristics and Antecedents of Progressive Multifocal Leukoencephalopathy in an Insured Population
Neurol 67:884-886, Eng,P.M.,et al, 2006

Immune Reconstitution Inflammatory Syndrome Associated with PML in AIDS: A Treatable Disorder
Neurol 67:1692-1694, Martinez,J.V.,et al, 2006

MR Imaging of Human Herpesvirus-6-Associated Encephalitis in 4 Patients with Anterograde Amnesia after Allogeneic Hematopoietic Stem-Cell Transplantation
AJNR 27:887-891, Gorniak,R.J.T.,et al, 2006

Clinicopath Conf, Diffuse Large B-Cell Lymphoma, EBV-Positive, with Immunosuppression
NEJM 354:1178-1184, Case 8-2006, 2006

What Went Wrong in the Natalizumab Trials?
Lancet 367:706-709, Langer-Gould,A.&Steinman,L., 2006

Seizures and Their Outcome in Progressive Multifocal Leukoencephalopathy
Neurol 66:262-264, Lima,M.A.,et al, 2006

Isolated Abducens Nerve Palsy as a Regional Variant of Guillain-Barre Syndrome
JNS 243:35-38, Tatsumoto, M.,et al, 2006

Sustained Recovery of Progressive Multifocal Leukoencephalopathy After Treatment with IL-2
Neurol 65:1510, Kunschner,L. &Scott,T.F., 2005

Anti-Sulfatide Antibodies in HIV-Infected Individuals with Sensory Neuropathy
Neurol 64:1632-1634, Lopate,G.,et al, 2005

Atypical PML Leading to a Diagnosis of Common Variable Immunodeficiency
Neurol 64:1661, Snyder,M.D.,et al, 2005

FDA Public Health advisory-Suspended Marketing of Tysabri (natalizumab)
www.fda.gov/cder/drug/advisory/natalizumab.htm.,(Feb 28), US Food and Drug Admin., 2005

JC Virus Granule Cell Neuronopathy: A Novel Clinical Syndrome Distinct from Progressive Multifocal Leukoencephalopathy
Ann Neurol 57:576-580, Koralnik,I.J.,et al, 2005

Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis
NEJM 353:369-374,414,432, Kleinschemidt-DeMasters,B.K. &Tyler,K.L., 2005

Progressive Multifocal Leukoencephalopathy After Natalizumab Therapy for Crohns Disease
NEJM 353:362-368, Van Assche,G.,et al, 2005

Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab
NEJM 353:375-381, Langer-Gould,A.,et al, 2005

Fatal Inflammatory AIDS-Associated PML with High CD4 Counts on HAART: A New Clinical Entity?
Neurol 63:2452-2453, Di Giambenedetto,S.,et al, 2004

Clinicopath Conf., Progessive Multifocal Leukoencephalopathy
NEJM 350:1884-1893, Case 14-2004, 2004

Pseudo-Subarachnoid Hemorrhage
Neurocritical Care 1:371-374, Cucchiara, B.,et al, 2004

Progressive Multifocal Leukoencephalopathy: Analysis of Lesion Development With Diffusion-Weighted MRI
Neuroradiol 45:717-721, Mader,I.,et al, 2003

Progressive Multifocal Leukoencephalopathy
Neurol 58:1825, Henderson,R.D.,et al, 2002

Lesions of the Corpus Callosum: MR Imaging and Differential Considerations in Adults and Children
AJR 179:251-257, Bourekas,E.C.,et al, 2002

HIV-associated Neurologic Disease Incidence Changes: Multicenter AIDS Cohort Study, 1990-1998
Neurol 56:257-260, Sacktor,N.,et al, 2001

Initial and Follow-up MR Imaging Findings in AIDS-Related Progressive Multifocal Leukoencephalopathy Treated with Highly Active Antiretroviral Therapy
AJNR 22:977-984, Thurnher,M.M.,et al, 2001

Human Herpesvirus 6 Limbic Encephalitis After Stem Cell Transplantation
Ann Neurol 50:612-619, Wainwright,M.S.,et al, 2001

Progressive Multifocal Leucoencephalopathy: Progress in the AIDS Era
JNNP 69:569-571, Manji,H. & Miller,R.F., 2000



Showing articles 100 to 150 of 3117 << Previous Next >>